Published in J Addict Med on November 05, 2014
Massage Impact on Pain in Opioid-dependent Patients in Substance Use Treatment. Int J Ther Massage Bodywork (2015) 0.75
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol (2010) 10.65
When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain (1995) 5.97
Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2008) 4.55
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA (2003) 4.25
Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment (2011) 4.21
The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res (2007) 4.01
Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend (2007) 3.44
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97
Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85
Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage (2000) 2.11
Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry (2001) 2.03
The clinical measurement of pain. Ann N Y Acad Sci (1960) 2.02
Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing. Qual Life Res (1997) 1.91
Development and psychometric analysis of the PROMIS pain behavior item bank. Pain (2009) 1.85
The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction (2008) 1.82
Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend (2004) 1.71
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict (2008) 1.52
Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain (2005) 1.48
Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend (2005) 1.38
Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis (2007) 1.34
Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32
Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. Pain Med (2008) 1.31
Health-related quality of life for adults participating in outpatient substance abuse treatment. Am J Addict (2003) 1.24
Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict (2009) 1.19
Comparison of opiate-primary treatment seekers with and without alcohol use disorder. J Subst Abuse Treat (2010) 1.05
Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment study. J Addict Med (2010) 1.05
The promise of PROMIS(®) for addiction. Drug Alcohol Depend (2011) 1.03
Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend (2012) 1.03
Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse (1996) 0.99
Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse (2008) 0.93
Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis. Am J Addict (2001) 0.92
Item banks for alcohol use from the Patient-Reported Outcomes Measurement Information System (PROMIS): use, consequences, and expectancies. Drug Alcohol Depend (2012) 0.89
Personality factors associated with methadone maintenance dose. Am J Drug Alcohol Abuse (2008) 0.85
Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug Alcohol Depend (2009) 0.83
Development of a computerized adaptive test for depression. Arch Gen Psychiatry (2012) 3.77
Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat (2003) 2.91
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict (2004) 2.85
Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry (2007) 2.80
Children of mothers with borderline personality disorder: identifying parenting behaviors as potential targets for intervention. Personal Disord (2012) 2.72
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55
Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep (2010) 2.40
Behavioral health insurance parity: does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act? Am J Psychiatry (2011) 2.24
Development of the CAT-ANX: a computerized adaptive test for anxiety. Am J Psychiatry (2014) 2.16
Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14
Which elements of improvement collaboratives are most effective? A cluster-randomized trial. Addiction (2013) 2.10
The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression. J Clin Psychiatry (2013) 2.10
Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat (2006) 2.08
Making "stone soup": improvements in clinic access and retention in addiction treatment. Jt Comm J Qual Patient Saf (2007) 1.96
Adoption of naltrexone to treat alcohol dependence. J Subst Abuse Treat (2005) 1.84
Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Drug Alcohol Depend (2008) 1.80
The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat (2010) 1.67
Addiction treatment agencies' use of data: a qualitative assessment. J Behav Health Serv Res (2006) 1.66
Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacol Ther (2005) 1.64
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J Subst Abuse Treat (2006) 1.61
Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry (2004) 1.59
Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. J Subst Abuse Treat (2004) 1.59
Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approach. Psychol Sci Q (2009) 1.56
Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med (2011) 1.45
Treatment expectancies, patient alliance, and outcome: further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol (2002) 1.45
Treating alcohol and drug use disorders. Health Aff (Millwood) (2013) 1.41
Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers. J Clin Psychiatry (2004) 1.41
Symptom reports in severe chronic insomnia. Sleep (2002) 1.35
Evidence for a single latent class of Diagnostic and Statistical Manual of Mental Disorders borderline personality pathology. Compr Psychiatry (2006) 1.32
Self- and other-reports of traits from the five-factor model: relations to personality disorder. J Pers Disord (2005) 1.27
Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. Am J Psychiatry (2007) 1.24
Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Aff (Millwood) (2013) 1.22
Differential functioning of the Beck depression inventory in late-life patients: use of item response theory. Psychol Aging (2002) 1.22
Management practices in substance abuse treatment programs. J Subst Abuse Treat (2009) 1.21
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Training future generations of mental health researchers: devising strategies for tough times. Acad Psychiatry (2007) 1.20
Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev (2004) 1.18
Neuroticism and affective instability: the same or different? Am J Psychiatry (2006) 1.17
A simplified technique for scoring DSM-IV personality disorders with the Five-Factor Model. Assessment (2005) 1.16
Disseminating quality improvement: study protocol for a large cluster-randomized trial. Implement Sci (2011) 1.13
Describing depression: congruence between patient experiences and clinical assessments. Br J Clin Psychol (2011) 1.11
Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation. Am J Drug Alcohol Abuse (2013) 1.11
Implementation of MET/CBT 5 for adolescents. J Behav Health Serv Res (2008) 1.10
Emotion assessment using the NIH Toolbox. Neurology (2013) 1.10
Narcissistic personality disorder: relations with distress and functional impairment. Compr Psychiatry (2007) 1.08
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend (2008) 1.07
Measuring depression using item response theory: an examination of three measures of depressive symptomatology. Int J Methods Psychiatr Res (2012) 1.05
Substance use and the quality of patient-provider communication in HIV clinics. AIDS Behav (2011) 1.05
From research to the real world: buprenorphine in the decade of the Clinical Trials Network. J Subst Abuse Treat (2010) 1.04
Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care. Clin Infect Dis (2006) 1.03
Facilitating outpatient treatment entry following detoxification for injection drug use: a multisite test of three interventions. Psychol Addict Behav (2009) 1.03
Screening for personality disorders. J Pers Disord (2007) 1.03
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02
Treatment utilization and satisfaction: examining the contributions of Axis II psychopathology and the Five-Factor Model of personality. J Pers Disord (2006) 1.02
Clarifying interpersonal heterogeneity in borderline personality disorder using latent mixture modeling. J Pers Disord (2013) 1.01
Negative affect and parental aggression in child physical abuse. Child Abuse Negl (2002) 1.01
Interpersonal and emotional experiences of social interactions in borderline personality disorder. J Nerv Ment Dis (2009) 1.01
Substance abuse treatment providers' involvement in research is associated with willingness to use findings in practice. J Subst Abuse Treat (2010) 1.00
The validity of the five-factor model prototypes for personality disorders in two clinical samples. Psychol Assess (2004) 0.99
Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav (2011) 0.99
Employing policy and purchasing levers to increase the use of evidence-based practices in community-based substance abuse treatment settings: reports from single state authorities. Eval Program Plann (2011) 0.97
Quantitative methods in psychiatric classification: the path forward is clear but complex: commentary on Krueger and Eaton (2010). Personal Disord (2010) 0.97
Understanding attitudes towards use of medication in substance abuse treatment: A multilevel approach. Psychol Serv (2009) 0.96
Using a standardized patient walk-through to improve implementation of clinical trials. J Subst Abuse Treat (2008) 0.96
Using clinician-rated five-factor model data to score the DSM-IV personality disorders. J Pers Assess (2010) 0.95
Anger, preoccupied attachment, and domain disorganization in borderline personality disorder. J Pers Disord (2009) 0.94
Examining the reliability and validity of clinician ratings on the Five-Factor Model Score Sheet. Assessment (2010) 0.94
Social networks in borderline personality disorder. J Pers Disord (2007) 0.94
Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care. J Addict Med (2010) 0.94
What's in a (neutral) face? Personality disorders, attachment styles, and the appraisal of ambiguous social cues. J Pers Disord (2004) 0.94
An application of item response theory to the DSM-III-R criteria for borderline personality disorder. J Pers Disord (2007) 0.93
Stability of borderline personality disorder features in girls. J Pers Disord (2010) 0.93
Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. Am J Manag Care (2011) 0.93
The role of attachment styles and interpersonal problems in suicide-related behaviors. Suicide Life Threat Behav (2008) 0.93
Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states. J Addict Dis (2009) 0.92
Improving substance abuse data systems to measure 'waiting time to treatment': lessons learned from a quality improvement initiative. Health Informatics J (2011) 0.92
Assessing fidelity of treatment delivery in group and individual 12-step facilitation. J Subst Abuse Treat (2012) 0.92
Comparisons across depression assessment instruments in adolescence and young adulthood: an item response theory study using two linking methods. J Abnorm Child Psychol (2013) 0.92
Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. Bipolar Disord (2005) 0.91
Refining the phenotype of borderline personality disorder: Diagnostic criteria and beyond. Personal Disord (2012) 0.91
Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abuse Treat (2010) 0.90
Preoccupied attachment and emotional dysregulation: specific aspects of borderline personality disorder or general dimensions of personality pathology? J Pers Disord (2013) 0.90
Costs of care for persons with opioid dependence in commercial integrated health systems. Addict Sci Clin Pract (2014) 0.89
Item banks for alcohol use from the Patient-Reported Outcomes Measurement Information System (PROMIS): use, consequences, and expectancies. Drug Alcohol Depend (2012) 0.89
Five-factor model prototypes for personality disorders: the utility of self-reports and observer ratings. Assessment (2004) 0.89
American Indians with substance use disorders: treatment needs and comorbid conditions. Am J Drug Alcohol Abuse (2012) 0.89
Prospective associations among borderline personality disorder symptoms, interpersonal problems, and aggressive behaviors. J Interpers Violence (2011) 0.88
A multilevel approach to predicting community addiction treatment attitudes about contingency management. J Subst Abuse Treat (2011) 0.88
Measurement of social capital among clinical research trainees. Clin Transl Sci (2013) 0.88
Days to treatment and early retention among patients in treatment for alcohol and drug disorders. Addict Behav (2011) 0.88
Efficiently assessing negative cognition in depression: an item response theory analysis of the Dysfunctional Attitude Scale. Psychol Assess (2007) 0.87
Borderline personality and substance use in women. Am J Addict (2006) 0.87
Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions. Eval Program Plann (2011) 0.87
Multimethod investigation of interpersonal functioning in borderline personality disorder. Personal Disord (2011) 0.87
Advancing recovery: implementing evidence-based treatment for substance use disorders at the systems level. J Stud Alcohol Drugs (2012) 0.86
Improving quality of care in substance abuse treatment using five key process improvement principles. J Behav Health Serv Res (2012) 0.86
An examination of the factor structure of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, narcissistic personality disorder criteria: one or two factors? Compr Psychiatry (2007) 0.86
Reducing errors of omission in chronic disease management. J Interprof Care (2005) 0.86
Integrating competing dimensional models of personality: linking the SNAP, TCI, and NEO using Item Response Theory. Personal Disord (2011) 0.86
What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations. J Healthc Qual (2015) 0.85